Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | KLK7 | P49862 | 1/20 | 0.37 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL638844 | 0.99 | TAAR1 (0.45) | TAAR1KMT2ATDP1ALDH1A1CNR1 | |
| SCHEMBL2231584 | 0.83 | TAAR1 (0.41) | TAAR1KMT2ATDP1ALDH1A1HSP90AA1 | |
| SCHEMBL640972 | 0.82 | TAAR1 (0.41) | TAAR1KMT2ATDP1ALDH1A1HSP90AA1 | |
| SCHEMBL2230591 | 0.81 | KMT2A (0.42) | TAAR1KMT2ATDP1ALDH1A1HSP90AA1 | |
| SCHEMBL916877 | 0.81 | KMT2A (0.41) | TAAR1KMT2ATDP1ALDH1A1HSP90AA1 | |
| SCHEMBL2231640 | 0.79 | TAAR1 (0.44) | TAAR1KMT2ATDP1ALDH1A1HSP90AA1 | |
| SCHEMBL636954 | 0.79 | MGLL (0.38) | TAAR1KMT2ATDP1ALDH1A1MEN1 | |
| SCHEMBL917276 | 0.78 | TAAR1 (0.45) | TAAR1KMT2ATDP1ALDH1A1HSP90AA1 | |
| SCHEMBL2230122 | 0.78 | TAAR1 (0.42) | TAAR1KMT2ATDP1ALDH1A1HSP90AA1 | |
| SCHEMBL636937 | 0.76 | TAAR1 (0.43) | TAAR1KMT2ATDP1HSP90AA1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170190657-A1 | ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE | XENOPORT, INC. (US) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170190657-A1 | ACYLOXYALKYL CARBAMATE PRODRUGS, METHODS OF SYNTHESIS AND USE | APEH, ABAT, SI | TAAR1 1740/4885KMT2A 2442/4885TDP1 852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.